A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Weight loss injectables like Ozempic have gained popularity in Bengaluru, with patients sourcing them from abroad. The ...

A revolutionary anti-fat pill which tricks the body into feeling full was launched on the NHS yesterday to tackle Britain's obesity epidemic. Thousands of overweight people will qualify for the ...

Anti-obesity drugs, specifically GLP-1 agonists, have been shown to benefit kidney transplant recipients with type 2 diabetes by reducing the risk of organ failure by 49% and decreasing mortality ...

A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...

State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...